We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Immune Support Formula (Star Combo Australia Pty Ltd)
Product Name
Immune Support Formula
Sponsor
ARTG details
- 377040
Date of review outcome
Date of publication
Sep-2025
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, use of this medicine may pose a safety risk for some people. Follow the recommended actions below.
What action should consumers take?
This medicine contains sucralose and sugar (glucose). Consider whether this medicine is right for you if you have allergies or sensitivities to these substances. If you develop a reaction, discontinue use and consult a suitably qualified health practitioner.
Be aware that this medicine may also not work as expected in relation to reducing the occurrence of common colds and the formation of collagen. If symptoms persist, talk to your health professional.
Consider whether this medicine is right for you given that the claim for helping to enhance or promote bone strength was not substantiated by the sponsor.
Be aware that this medicine may also not work as expected in relation to reducing the occurrence of common colds and the formation of collagen. If symptoms persist, talk to your health professional.
Consider whether this medicine is right for you given that the claim for helping to enhance or promote bone strength was not substantiated by the sponsor.
Review scope
Targeted (see Additional Information below)
Information reviewed
ARTG Record, Evidence, Labels, Website
Issues related to safety
This medicine contains sucralose and sugars, neither of which were declared on the label. Sucralose and sugars are required to be declared on the labels of medicines as they may cause adverse reactions in individuals sensitive to such substances. In addition, the label for this medicine was missing the mandatory warning statement 'If symptoms persist, talk to your health professional'. This warning statement is necessary to ensure the safe use of this medicine. While these omissions are unacceptable, current data indicates that the use of this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The sponsor did not hold sufficient evidence to support the claim related to helping enhance or promote bone strength. The limitations with the evidence included the study population, active ingredient, dosage, and the results of some studies not being relevant to this medicine. Some of the evidence provided was not of sufficient quality.
In addition, the label for this medicine claimed it could reduce the occurrence of common colds and form collagen. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
In addition, the label for this medicine claimed it could reduce the occurrence of common colds and form collagen. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor cancelled this medicine and withdrew it from further supply.
Additional information
This medicine was targeted to check its compliance in relation to claims about enhancing or promoting bone strength